Trigg Michael E, Nadkarni Vinay, Chidekel Aaron, McKay Charles, Meek Rita, Griffin Gregory, Edelson Maureen, Reilly Anne, Peoples Joseph, Levine Stuart, Meier Frederick
Division of Blood & Bone Marrow Transplantation, Department of Pediatrics, A.I. duPont Hospital for Children, Wilmington, Delaware 19803, USA.
Paediatr Drugs. 2002;4(3):205-8. doi: 10.2165/00128072-200204030-00007.
We report the case of a 7-year-old boy with Fanconi's anemia, who underwent a bone marrow transplant using an unrelated donor, and who received an inadvertent dose of cytarabine (cytosine arabinoside). The cytarabine was given by mistake 6 months following transplant. This caused excessive toxicity to many systems, including the pulmonary and renal systems. The patient recovered from the episode, but this article further highlights the acute adverse effects of cytarabine. Furthermore, it is the first report of excessive toxicity to cytarabine in a child with Fanconi's anemia. The article also highlights the problems of medication administration errors, particularly in those exquisitely sensitive to the effects of toxic drugs.
我们报告了一名患有范可尼贫血的7岁男孩的病例,该男孩接受了来自非亲属供体的骨髓移植,并意外接受了一剂阿糖胞苷(阿拉伯糖胞嘧啶)。阿糖胞苷在移植后6个月误给。这对包括肺和肾系统在内的许多系统造成了过度毒性。患者从这一事件中康复,但本文进一步强调了阿糖胞苷的急性不良反应。此外,这是范可尼贫血患儿中阿糖胞苷过度毒性的首例报告。本文还强调了给药错误的问题,特别是在那些对毒性药物影响极为敏感的患者中。